Ken Griffin Icu Medical Inc Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$114.88 - $182.17 $310,176 - $491,858	2,700 Added 385.71%	3,400 $619,000
Q2 2024 Aug 14, 2024	SELL	$94.53 - $120.55 $9,453 - $12,055	-100 Reduced 12.5%	700 $83,000
Q1 2024 May 15, 2024	SELL	$86.88 - $112.48 $408,336 - $528,656	-4,700 Reduced 85.45%	800 $85,000
Q4 2023 Feb 14, 2024	BUY	$81.08 - $119.29 $227,024 - $334,012	2,800 Added 103.7%	5,500 $548,000
Q3 2023 Nov 14, 2023	BUY	$115.27 - $182.23 $149,851 - $236,899	1,300 Added 92.86%	2,700 $321,000
Q2 2023 Aug 14, 2023	SELL	$161.03 - $209.15 $869,562 - $1.13 Million	-5,400 Reduced 79.41%	1,400 $249,000
Q1 2023 May 15, 2023	BUY	$153.15 - $198.21 $91,890 - $118,926	600 Added 9.68%	6,800 $1.12 Million
Q4 2022 Feb 14, 2023	SELL	$136.25 - $165.56 $531,375 - $645,684	-3,900 Reduced 38.61%	6,200 $976,000
Q3 2022 Nov 14, 2022	BUY	$149.44 - $188.1 $747,200 - $940,500	5,000 Added 98.04%	10,100 $1.52 Million

308

24.1M

51K

54.8K

Ticker ICUI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 23,899,400
Market Cap $3.7B
Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.